ArticleCell reports2022

Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection.

Kylie M Konrath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.